Roger Pertwee MA, D.Phil. DSc. (Oxford) is an Emeritus Professor at the University of Aberdeen, still actively engaged in cannabinoid research. He is also an Honorary Fellow of the British Pharmacological Society (BPS), has served as President (twice) of the International Cannabinoid Research Society (ICRS) and as Chairman of the International Association for Cannabinoid Medicines (IACM), and is on the IACM (and ICRS) Board of Directors. His awards include (1) the 2002 Mechoulam Award and the 2018 Lifetime Achievement Award from the International Cannabinoid Research Society, (2) the 2011 Wellcome Gold Medal “for outstanding contributions to pharmacology, based mainly on research achievements, (3) the 2013 International Association for Cannabinoid Medicines Special Award, and (4) a 2019 Highly Cited Researcher Award from Clarivate Analytics in recognition of the production of Pharmacology papers ranking in the top 1% by citations. His research has focused mainly on the pharmacology and therapeutic potential of cannabinoids. His research achievements include the joint discovery of delta-9- tetrahydrocannabivarin in cannabis, and of endocannabinoids, the discovery of a CB1 receptor allosteric site, and significant contributions to the pharmacological characterization of phytocannabinoids and notable synthetic cannabinoids. See also https://www.abdn.ac.uk/people/rgp.
